Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin‐based chemotherapy

Hepatic sinusoidal obstruction syndrome during oxaliplatin‐based chemotherapy has been shown to be associated with severe steatohepatitis. Gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging may identify various features of hepatic sinusoidal obstruction s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Shinichiro, Okudaira, Sadayuki, Kobayashi, Kazuma, Kanetaka, Kengo, Eguchi, Susumu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389491/
https://www.ncbi.nlm.nih.gov/pubmed/30847217
http://dx.doi.org/10.1002/ccr3.1935
Descripción
Sumario:Hepatic sinusoidal obstruction syndrome during oxaliplatin‐based chemotherapy has been shown to be associated with severe steatohepatitis. Gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging may identify various features of hepatic sinusoidal obstruction syndrome, even when the lesion cannot be differentiated from sinusoidal obstruction syndrome by other imaging tools.

Ejemplares similares